- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05889702
Kentucky Access to Recovery Evaluation
Evaluation of the Kentucky Access to Recovery (KATR) Linkage Strategy
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Kentucky
-
Berea, Kentucky, United States, 40403
- FAHE
-
Lexington, Kentucky, United States, 40506
- University of Kentucky
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- be in SUD treatment or have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use
- be a first-time participant in KATR
- be in early stages of recovery (less than one year in recovery)
- be a resident of a KATR service county
- be at or below the 200% federal poverty level
- not have financial resources available through other funding mechanisms for RSSs
- be 18 years of age and older
- be in need of recovery supports that will enhance their likelihood of staying in recovery
Exclusion Criteria:
- Under 18
- Participated in KATR previously
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
KATR Clients
participants in the early stages of recovery and in substance use disorder (SUD) treatment; or those that have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use.
|
The Kentucky ATR (KATR) strategy is a 25-county program that links county residents at or below the 200% national poverty level who have an illicit SUD and are in treatment or early recovery to evidence-based RSSs such as recovery housing, and to other RSSs. The KATR linkage approach uses vouchers as a linkage strategy for individuals in SUD treatment who have no other funding options to acquire critical RSSs. As such, KATR's linkage through vouchers is a "last resort" approach for linking to RSSs. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Recovery Capital per person
Time Frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Recovery capital will be assessed using the Brief Assessment of Recovery Capital-10 (BARC-10); 10 item survey unidimensional measure of recovery capital, scores may range from 6-60 at any given time.
Evaluation of the measure suggests that individuals who have a higher score are likely to reach or sustain a year or longer of recovery from substance use disorder.
|
Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Change in number of drug overdoses per person
Time Frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Number of drug overdoses will be assessed with the following survey question: In the past 30 days, did you experience an overdose or take too much of a substance that resulted in needing supervision or medical attention?
|
Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Change in number of days of illicit substance use per person
Time Frame: Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Number of days illicit substance use will be assessed with the following survey question: During the past 30 days, how many days have you used any substance
|
Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Terry Bunn, PhD, University of Kentucky
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 81811
- R01CE003513-01-00 (Other Grant/Funding Number: CDC)
- R01CE003513-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
Clinical Trials on KATR Linkage Strategy
-
RTI InternationalRecruitingSickle Cell DiseaseUnited States
-
Lisa MetschNational Institute of Dental and Craniofacial Research (NIDCR)CompletedHIV Infections | Mouth Diseases | Oral Health CareUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)SuspendedDepressive Disorder | Bipolar Disorder | Mental Disorders, Severe | Schizophrenia and Related DisordersUnited States
-
Texas Christian UniversityCompletedMapping Enhanced Counseling (MEC) | Active Linkage (AL)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Duke UniversityCompletedHuman Papilloma Virus Infection | Carcinoma in Situ of Uterine CervixKenya
-
Hospices Civils de LyonNot yet recruiting
-
China National Center for Cardiovascular DiseasesUnknown
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedPsychotic Disorders | Psychosis Nos/OtherUnited States
-
Liverpool School of Tropical MedicineLondon School of Hygiene and Tropical Medicine; McGill University; University... and other collaboratorsUnknownTuberculosis | Hiv | Tuberculosis, PulmonaryMalawi